ACRS — ACLARIS THERAPEUTICS INC

Ownership history in ALGERT GLOBAL LLC  ·  9 quarters on record

This page tracks every 13F SEC filing in which ALGERT GLOBAL LLC reported a position in ACLARIS THERAPEUTICS INC (ACRS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2023 Q3)
Avg. % of fund
0.0%
First filed
2022 Q4
Last filed
2025 Q3
Quarters held
9
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 65,630 +25,780 +64.7% 0.00% $125K $1.90
2025 Q2 UNCHANGED 39,850 — 0% 0.00% $57K $1.42
2025 Q1 ADDED 39,850 +20,080 +101.6% 0.00% $61K $1.53
2024 Q3 ADDED 19,770 +7,990 +67.8% 0.00% $23K $1.15
5 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    ACRS price (monthly, adj. close)

Other funds also holding ACRS

As of 2025 Q4 — sorted by position size

BML Capital Management, LLC 3Y 37.08% Aldebaran Capital, LLC 3Y 2.58% Vivo Capital, LLC 3Y 7Y 1.73% Decheng Capital LLC 1.64% KOTLER KEVIN 1.2% NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 3Y 7Y 0.82% Rock Springs Capital Management LP 3Y 7Y 0.69% Palo Alto Investors LP 3Y 7Y 0.66% Three Bridge Wealth Advisors, LLC 3Y 0.57% Aisling Capital Management LP 3Y 7Y 0.27%
← Back to ALGERT GLOBAL LLC Holdings